Cel AI PLC Board change

RNS Number : 0802M

Cel AI PLC

30 April 2024

 

30 April 2024

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

CEL AI plc

 

("Cel AI" or the "Company")

 

Board change

 

Cel AI (LSE: CLAI), a company specialising in cutting-edge artificial intelligence (AI) to deliver tailored beauty advice and product recommendations as well as next-generation skincare and wellness products, announces that the Company and Gill Whitty Collins have agreed that Gill will cease to be a non-executive director of the Company with effect from 30 April 2024, being the end of her fixed term engagement with the Company.

 

The Board would like to take this opportunity to thank Gill Whitty Collins for her contribution to the Company and wish her well for the future.

 

For further information please contact:

Cellular Goods
Michael Edwards Director	via FSCF [phone]
First Sentinel Corporate Finance (FSCF)
Investor Relations Rebecca Noonan [e-mail] Media Relations Rebecca Noonan [e-mail] Corporate Broker & Advisor Brian Stockbridge	[phone]     [phone]     [phone]
Novum Securities
Corporate Broker Colin Rowbury Jon Belliss	[phone]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOAQKPBNBBKDOQB